Beyond carboplatin/paclitaxel: Choice of adjuvant chemotherapy regimen in mucinous ovarian carcinoma

被引：0
|
作者：
Barkdull, Savannah [1 ]
Zhang, Yingao [1 ]
Legarreta, Alejandra Flores [2 ]
Frumovitz, Michael [2 ]
Sood, Anil [2 ]
机构：
[1] Baylor Coll Med, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
10.1016/j.ygyno.2024.07.523
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2232
引用
收藏
页码：S350 / S350
页数：1
相关论文
共 50 条
  • [21] Adjuvant Radiotherapy "Sandwiched" with Carboplatin/Paclitaxel Chemotherapy for Stage III/IV Uterine Papillary Serous Carcinoma
    D'Souza, D.
    Lupe, K.
    Kwon, J. S.
    Wiebe, E.
    Whiston, F.
    Carey, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S371 - S372
  • [22] Carboplatin/paclitaxelHistological changes in ovarian mucinous carcinoma: case report
    Reactions Weekly, 2021, 1853 (1) : 110 - 110
  • [23] A Pilot Study Evaluating a Novel Regimen Comprised of Carboplatin, Paclitaxel, and Bevacizumab for Advanced-Stage Ovarian Carcinoma
    Brown, John V., III
    Micha, John P.
    Rettenmaier, Mark A.
    Abaid, Lisa N.
    Lopez, Katrina L.
    Goldstein, Bram H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (07) : 1132 - 1136
  • [24] Carboplatin and paclitaxel adjuvant chemotherapy in primitive neuroectodermal tumor of the uterine corpus
    Shah, Jay P.
    Jelsema, Jodilyn
    Bryant, Christopher S.
    Ali-Fehmi, Rouba
    Malone, John M., Jr.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (02) : E6 - E9
  • [25] Prolonged remission of recurrent cervical carcinoma following paclitaxel and carboplatin chemotherapy with paclitaxel maintenance chemotherapy
    Micha, John P.
    Sassoon, Aaron F.
    Wong, Humberto
    Goldstein, Bram H.
    ANTI-CANCER DRUGS, 2015, 26 (07) : 793 - 796
  • [26] Correlation of in vitro chemotherapy drug resistance assay to clinical response to carboplatin and paclitaxel combination chemotherapy in ovarian carcinoma.
    Cheng, Kit
    Shapira, Iuliana
    Rosen, Lisa M.
    John, Veena S.
    Lovecchio, John L.
    Menzin, Andrew
    Whyte, Jill Suzanne
    Dos Santos, Lisa A.
    Contreras, Diana
    Shih, Karin
    Roy, Rajasree
    Lee, Annette
    Hayes, Christi
    Ahmad, Nazish
    Tandon, Pragati
    Hoffman, Mark Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Comparison of the Short term Efficacy and Serum Markers between Lobaplatin/Paclitaxel and Carboplatin/Paclitaxel-based Adjuvant Chemotherapy in Patients with Ovarian Cancer
    Li, Zhihui
    Chen, Ying
    Zhang, Shihong
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 : 23 - 29
  • [28] A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen
    Schlappe, Brooke A.
    Zhou, Qin C.
    O'Cearbhaill, Roisin
    Iasonos, Alexia
    Soslow, Robert A.
    Abu-Rustum, Nadeem R.
    Mueller, Jennifer J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (05) : 904 - 909
  • [29] Risk factors for recurrence of optimally staged/debulked ovarian or tubal cancer patients with adjuvant paclitaxel/carboplatin combination chemotherapy
    Kojimahara, T.
    Nakahara, K.
    Osakabe, M.
    Saitoh-Sekiguchi, M.
    Hayasaka, T.
    Motoyama, T.
    Kurachi, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Chemotherapy with paclitaxel plus carboplatin for relapsed advanced thymic carcinoma
    Song, Zhengbo
    JOURNAL OF THORACIC DISEASE, 2014, 6 (12) : 1808 - 1812
12345